Drug
Vib7734
Vib7734: highest development phase Phase 1, developed by Horizon Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Horizon Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| VIB7734 NCT04526912 | Phase 1 | Acute Lung Injury |
Latest
No recent events.
Follow Vib7734 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.